10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2018 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2018 10-K (Filed: Feb 13, 2019) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
| Revenues: | |||
| Total revenues | $ 23,747 | 22,849 | 22,991 |
| Operating expenses: | |||
| Cost of sales | 4,101 | 4,069 | 4,162 |
| Research and development | 3,737 | 3,562 | 3,840 |
| Selling, general and administrative | 5,332 | 4,870 | 5,062 |
| Other | 314 | 375 | 133 |
| Total operating expenses | 13,484 | 12,876 | 13,197 |
| Operating income | 10,263 | 9,973 | 9,794 |
| Interest expense, net | 1,392 | 1,304 | 1,260 |
| Interest and other income, net | 674 | 928 | 629 |
| Income before income taxes | 9,545 | 9,597 | 9,163 |
| Provision for income taxes | 1,151 | 7,618 | 1,441 |
| Net income | 8,394 | 1,979 | 7,722 |
| Earnings per share: | |||
| Basic (in usd per share) | 12.70 | 2.71 | 10.32 |
| Diluted (in usd per share) | 12.62 | 2.69 | 10.24 |
| Shares used in the calculation of earnings per share: | |||
| Basic (in shares) | 661 | 731 | 748 |
| Diluted (in shares) | 665 | 735 | 754 |
| Product and Service | |||
| Product | |||
| Product sales | 22,533 | 21,795 | 21,892 |
| Other | |||
| Total revenues | 1,214 | 1,054 | 1,099 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2018 | |||
Consolidated Statements of Comprehensive Income | |||
Period Ending Dec 31, 2018 10-K (Filed: Feb 13, 2019) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
| Net income | $ 8,394 | 1,979 | 7,722 |
| Other comprehensive (loss) income, net of reclassification adjustments and taxes: | |||
| (Losses) gains on foreign currency translation | (141) | 81 | (99) |
| Gains (losses) on cash flow hedges | 247 | (288) | (15) |
| (Losses) gains on available-for-sale securities | (185) | (6) | 122 |
| Other | (2) | 5 | 1 |
| Other comprehensive (loss) income, net of tax | (81) | (208) | 9 |
| Comprehensive income | 8,313 | 1,771 | 7,731 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2018 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2018 10-K (Filed: Feb 13, 2019) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
| Cash flows from operating activities: | |||
| Net income | $ 8,394 | 1,979 | 7,722 |
| Depreciation and amortization | 1,946 | 1,955 | 2,105 |
| Stock-based compensation expense | 311 | 329 | 311 |
| Deferred income taxes | (363) | (1,330) | 183 |
| Other items, net | 386 | 334 | 32 |
| Changes in operating assets and liabilities, net of acquisitions: | |||
| Trade receivables, net | (378) | (58) | (214) |
| Inventories | (3) | 133 | (80) |
| Other assets | 35 | (24) | (128) |
| Accounts payable | (143) | 424 | (44) |
| Accrued income taxes, net | (361) | 523 | (301) |
| Long-term tax liabilities | 258 | 6,681 | 445 |
| Other liabilities | 1,214 | 231 | 323 |
| Net cash provided by operating activities | 11,296 | 11,177 | 10,354 |
| Cash flows from investing activities: | |||
| Purchases of marketable securities | (18,741) | (33,607) | (28,094) |
| Proceeds from sales of marketable securities | 28,356 | 24,240 | 17,958 |
| Proceeds from maturities of marketable securities | 5,412 | 6,174 | 2,459 |
| Purchases of property, plant and equipment | (738) | (664) | (738) |
| Cash acquired in acquisition, net of cash paid | 195 | (19) | 0 |
| Other | (145) | (148) | (243) |
| Net cash provided by (used in) investing activities | 14,339 | (4,024) | (8,658) |
| Cash flows from financing activities: | |||
| Net proceeds from issuance of debt | 0 | 4,476 | 7,318 |
| Repayment of debt | (1,121) | (4,405) | (3,725) |
| Repurchases of common stock | (17,794) | (3,160) | (2,965) |
| Dividends paid | (3,507) | (3,365) | (2,998) |
| Withholding taxes arising from shares withheld for share-based payments | (126) | (191) | (260) |
| Other | 58 | 51 | 31 |
| Net cash used in financing activities | (22,490) | (6,594) | (2,599) |
| Increase (decrease) in cash and cash equivalents | 3,145 | 559 | (903) |
| Cash and cash equivalents at beginning of year | 3,800 | 3,241 | |
| Cash and cash equivalents at end of year | 6,945 | 3,800 | 3,241 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
AMGEN INC | ||
Ticker: AMGN Fiscal Year: 2018 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2018 10-K (Filed: Feb 13, 2019) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2018 | Dec 31, 2017 | |
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $ 6,945 | 3,800 |
| Marketable securities | 22,359 | 37,878 |
| Trade receivables, net | 3,580 | 3,237 |
| Inventories | 2,940 | 2,834 |
| Other current assets | 1,794 | 1,727 |
| Total current assets | 37,618 | 49,476 |
| Property, plant and equipment, net | 4,958 | 4,989 |
| Intangible assets, net | 7,443 | 8,609 |
| Goodwill | 14,699 | 14,761 |
| Other assets | 1,698 | 2,119 |
| Total assets | 66,416 | 79,954 |
| LIABILITIES AND STOCKHOLDERS EQUITY | ||
| Current liabilities: | ||
| Accounts payable | 1,207 | 1,352 |
| Accrued liabilities | 7,862 | 6,516 |
| Current portion of long-term debt | 4,419 | 1,152 |
| Total current liabilities | 13,488 | 9,020 |
| Long-term debt | 29,510 | 34,190 |
| Long-term deferred tax liabilities | 864 | 1,166 |
| Long-term tax liabilities | 8,770 | 9,099 |
| Other noncurrent liabilities | 1,284 | 1,238 |
| Contingencies and commitments | ||
| Stockholders equity: | ||
| Common stock and additional paid-in capital; $0.0001 par value per share; 2,750.0 shares authorized; outstanding629.6 shares in 2018 and 722.2 shares in 2017 | 31,246 | 30,992 |
| Accumulated deficit | (17,977) | (5,072) |
| Accumulated other comprehensive loss | (769) | (679) |
| Total stockholders equity | 12,500 | 25,241 |
| Total liabilities and stockholders equity | 66,416 | 79,954 |
| External Links | |
| AMGEN INC (AMGN) Fiscal Year 2018 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |